405 related articles for article (PubMed ID: 27582427)
1. Clonal cooperativity in heterogenous cancers.
Zhou H; Neelakantan D; Ford HL
Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
[TBL] [Abstract][Full Text] [Related]
2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
3. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
Brychtová V; Valík V; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity in epigenetic patterns.
Assenov Y; Brocks D; Gerhäuser C
Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
[TBL] [Abstract][Full Text] [Related]
5. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
Marusyk A; Janiszewska M; Polyak K
Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
[TBL] [Abstract][Full Text] [Related]
6. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers.
Cleary AS; Leonard TL; Gestl SA; Gunther EJ
Nature; 2014 Apr; 508(7494):113-7. PubMed ID: 24695311
[TBL] [Abstract][Full Text] [Related]
7. Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data.
Lee ND; Kaveh K; Bozic I
Semin Cancer Biol; 2023 Jul; 92():61-73. PubMed ID: 37023969
[TBL] [Abstract][Full Text] [Related]
8. Intratumor heterogeneity: nature and biological significance.
Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
[TBL] [Abstract][Full Text] [Related]
9. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.
Lyons JG; Lobo E; Martorana AM; Myerscough MR
Clin Exp Metastasis; 2008; 25(6):665-77. PubMed ID: 18071912
[TBL] [Abstract][Full Text] [Related]
10. The role of clonal communication and heterogeneity in breast cancer.
Martín-Pardillos A; Valls Chiva Á; Bande Vargas G; Hurtado Blanco P; Piñeiro Cid R; Guijarro PJ; Hümmer S; Bejar Serrano E; Rodriguez-Casanova A; Diaz-Lagares Á; Castellvi J; Miravet-Verde S; Serrano L; Lluch-Senar M; Sebastian V; Bribian A; López-Mascaraque L; López-López R; Ramón Y Cajal S
BMC Cancer; 2019 Jul; 19(1):666. PubMed ID: 31277602
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of intratumor heterogeneity: challenges and opportunities.
Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
[TBL] [Abstract][Full Text] [Related]
12. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
Marusyk A; Tabassum DP; Altrock PM; Almendro V; Michor F; Polyak K
Nature; 2014 Oct; 514(7520):54-8. PubMed ID: 25079331
[TBL] [Abstract][Full Text] [Related]
13. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
Ohsawa S; Takemoto D; Igaki T
J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
[TBL] [Abstract][Full Text] [Related]
14. Deciphering intratumor heterogeneity using cancer genome analysis.
Ryu D; Joung JG; Kim NK; Kim KT; Park WY
Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
[TBL] [Abstract][Full Text] [Related]
15. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
16. Tumor heterogeneity: causes and consequences.
Marusyk A; Polyak K
Biochim Biophys Acta; 2010 Jan; 1805(1):105-17. PubMed ID: 19931353
[TBL] [Abstract][Full Text] [Related]
17. [Tumor genetic heterogeneity].
Yang YL; Chu JY; Wang MR
Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
[TBL] [Abstract][Full Text] [Related]
18. The challenges of tumor genetic diversity.
Mroz EA; Rocco JW
Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
[TBL] [Abstract][Full Text] [Related]
19. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
